|3Dec 23, 6:00 AM ET

MERCK SHARP & DOHME LLC 3

3 · Personalis, Inc. · Filed Dec 23, 2024

Insider Transaction Report

Form 3
Period: 2024-12-19
Holdings
  • Common Stock, $0.0001 par value per share

    (indirect: See footnotes)
    14,044,943
Footnotes (3)
  • [F1]On December 19, 2024, Merck Sharp & Dohme LLC ("MSD") entered into an Investment Agreement with Personalis, Inc. (the "Company"), pursuant to which MSD purchased from the Company 14,044,943 shares of the Company's common stock, par value $0.0001 per share, at a price per share of $3.56.
  • [F2]MSD is a direct wholly-owned subsidiary of Merck & Co., Inc. ("Merck", and together with MSD, the "Reporting Persons").
  • [F3]Each of the Reporting Persons declare that the filing of this Form 3 shall not be construed as an admission that the Reporting Persons are the beneficial owners of any securities reported in this Form 3.

Documents

1 file
  • 3
    tm2431704-2_3seq1.xmlPrimary

    OWNERSHIP DOCUMENT